HPS Pharmacies wish to advise that GlaxoSmithKline Australia, in consultation with the Therapeutic Goods Administration have given notice of an urgent drug recall of:
Zovirax® Ophthalmic Ointment
|Presentation||Aciclovir 3% (30mg/g) tube|
|Expiry Date||Oct, 2015||Feb, 2016|
This recall has been issued due to the potential contamination of these two batches of Zovirax® Ophthalmic Ointment with metal filaments. Filaments found in the raw materials range in size from 150 to 850µm, which is equivalent to the size of sand grains.
Due to these batches representing a significant proportion of stock available, and no other brand of aciclovir ophthalmic ointment being available in Australia, supplies are now constrained to meet the emergency needs of clients. Supply is not expected to return to normal until the second quarter of 2015.
No other batches of Zovirax® Ophthalmic Ointment, or other Zovirax® products, are affected by this recall.
Please inspect your stocks and quarantine all units for return to your supplier. Any items supplied by HPS Pharmacies should be returned to the pharmacy for processing.
Retain this notice in a prominent position, including in other related business units until normal supply resumes. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies, or GlaxoSmithKline directly on 1800 064 162.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.